Results 71 to 80 of about 19,861 (100)

Pathogenic mechanism of extracranial arteriovenous malformations: insights from clinical, pathological, and genetic analyses. [PDF]

Virchows Arch
Hirose K, Hori Y, Maruyama K, Motooka D, Hata K, Tahara S, Matsui T, Nojima S, Kohara M, Imanaka-Yoshida K, Toyosawa S, Morii E.   +11 more
europepmc   +1 more source

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia. [PDF]

Ann Hematol
Yuan R, Xie Y, Miron PM, Higgins AW, Hutchinson L, Cerny J, Patel SA.   +6 more
europepmc   +1 more source

The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation. [PDF]

Oncotarget
Ofosu-Asante K, Lazarte JMS, Burra AG, Lamango NS.   +3 more
europepmc   +1 more source

STK38 Kinase Promotes Cell Migration Induced by Oncogenic Ras via MerTK Activation. [PDF]

Int J Mol Sci
Ohta S, Tago K, Kasashima K, Ebina M, Tominaga K.   +4 more
europepmc   +1 more source

Proto-Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal Cancer. [PDF]

Cancer Med
Kim D, Sharif S, Garay JAR, Bhakta AS, Boland PM, Cavnar MJ, Churchman ML, Hatoum H, Huang LC, Kim J, Kim R, Lentz RW, Mukherjee S, O'Donnell MT, Quartey B, Reilley MJ, Rounbehler RJ, Salhia B, Schneider BP, Chan CH.   +19 more
europepmc   +1 more source

KLF family of proteins in gastrointestinal tumors (Review). [PDF]

Oncol Lett
Zhang J, Zhao R, Yang P, Zhu Y, Zhu B.
europepmc   +1 more source

Dysregulation of MicroRNAs in Hepatocellular Carcinoma: Targeting Oncogenic Signaling Pathways for Innovative Therapies. [PDF]

Int J Mol Sci
Zarlashat Y, Halász J, Dósa E.
europepmc   +1 more source

KRAS G12R in pancreatic cancer: why this mutation resists current inhibitor strategies. [PDF]

Oncologist
Kern KA.
europepmc   +1 more source

TARDBP Mediates the MAP3K11/SLC3A2/GPX4 Axis in Alzheimer's Disease Rats by Enhancing KRAS mRNA Stability. [PDF]

J Cell Mol Med
Zhao Q, Yu Y, Wang F, Wang Y, Shao P, Zhao L.   +5 more
europepmc   +1 more source